Lytic infection by the Epstein-Barr virus (EBV) poses numerous health risks, such as infectious mononucleosis and lymphoproliferative disorder. We demonstrate that JQ1 and other BET inhibitors block t
The miRNA expression profiles of of EBV-infected YT and NK92 cells are compared. YT cells have weaker expression of T-bet and IFNg than NK92 cells. It was found that the EBV-encoded miR-BART20-5p inh
To examine the effect of Epstein-Barr virus (EBV) infection in primary B cells, we infected B cells from a healthy volunteer with EBV in vitro and harvested them after 48 hours.
